Literature DB >> 28567791

AMELIORATION OF THE DELETERIOUS PLEIOTROPIC EFFECTS OF AN ADAPTIVE MUTATION IN BACILLUS SUBTILIS.

Frederick M Cohan1, Elaine C King1, Piotr Zawadzki1.   

Abstract

The deleterious pleiotropic effects of an adaptive mutation may be ameliorated by one of two modes of evolution: (1) by replacement, in which an adaptive mutation with harmful pleiotropic effects is replaced by one that confers an equal benefit but at less cost; or (2) by compensatory evolution, in which natural selection favors modifiers at other loci that compensate for the deleterious effects of the mutant allele. In this study, we have measured the potential of these two modes of evolution to ameliorate the deleterious pleiotropic effects of resistance to the antibiotic rifampicin in the soil bacterium Bacillus subtilis. One approach was to measure the fitness cost of a series of spontaneous rifampicin-resistance mutations from each of several strains. The potential for amelioration by the replacement mode was estimated by the variation in fitness cost among the mutants of a single strain. Another approach was to introduce a series of different rifampicin-resistance alleles into a diversity of strains, and to measure the fitness cost of rifampicin resistance for each allele-by-strain combination. The potential for amelioration by the replacement mode was estimated by the variation in fitness costs among rifampicin-resistance alleles; the potential for compensatory evolution was estimated by variation in the fitness cost of rifampicin resistance among strains. This study has shown that the cost of rifampicin resistance may be ameliorated by both the compensatory and replacement modes. © 1994 The Society for the Study of Evolution.

Entities:  

Keywords:  Bacillus subtilis; compensatory evolution; fitness; mutation; pleiotropy; resistance; rifampicin

Year:  1994        PMID: 28567791     DOI: 10.1111/j.1558-5646.1994.tb01296.x

Source DB:  PubMed          Journal:  Evolution        ISSN: 0014-3820            Impact factor:   3.694


  12 in total

1.  Divergence in fitness and evolution of drug resistance in experimental populations of Candida albicans.

Authors:  L E Cowen; L M Kohn; J B Anderson
Journal:  J Bacteriol       Date:  2001-05       Impact factor: 3.490

2.  Molecular genetic and structural modeling studies of Staphylococcus aureus RNA polymerase and the fitness of rifampin resistance genotypes in relation to clinical prevalence.

Authors:  A J O'Neill; T Huovinen; C W G Fishwick; I Chopra
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

Review 3.  Evaluating the fate of genetically modified microorganisms in the environment: are they inherently less fit?

Authors:  R E Lenski
Journal:  Experientia       Date:  1993-03-15

4.  No fitness cost of glyphosate resistance endowed by massive EPSPS gene amplification in Amaranthus palmeri.

Authors:  Martin M Vila-Aiub; Sou S Goh; Todd A Gaines; Heping Han; Roberto Busi; Qin Yu; Stephen B Powles
Journal:  Planta       Date:  2014-01-03       Impact factor: 4.116

Review 5.  Strain diversity, epistasis and the evolution of drug resistance in Mycobacterium tuberculosis.

Authors:  S Borrell; S Gagneux
Journal:  Clin Microbiol Infect       Date:  2011-06       Impact factor: 8.067

6.  Effects of host plant and genetic background on the fitness costs of resistance to Bacillus thuringiensis.

Authors:  B Raymond; D J Wright; M B Bonsall
Journal:  Heredity (Edinb)       Date:  2010-06-02       Impact factor: 3.821

7.  The Spectrum of Spontaneous Rifampin Resistance Mutations in the Bacillus subtilis rpoB Gene Depends on the Growth Environment.

Authors:  Joss D Leehan; Wayne L Nicholson
Journal:  Appl Environ Microbiol       Date:  2021-09-08       Impact factor: 4.792

8.  Environmental Dependence of Competitive Fitness in Rifampin-Resistant rpoB Mutants of Bacillus subtilis.

Authors:  Joss D Leehan; Wayne L Nicholson
Journal:  Appl Environ Microbiol       Date:  2022-01-19       Impact factor: 5.005

9.  Impact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosis.

Authors:  Sebastian Gagneux; Marcos V Burgos; Kathryn DeRiemer; Antonio Encisco; Samira Muñoz; Phillip C Hopewell; Peter M Small; Alexander S Pym
Journal:  PLoS Pathog       Date:  2006-06-16       Impact factor: 6.823

10.  Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.

Authors:  Keira A Cohen; Thomas Abeel; Abigail Manson McGuire; Christopher A Desjardins; Vanisha Munsamy; Terrance P Shea; Bruce J Walker; Nonkqubela Bantubani; Deepak V Almeida; Lucia Alvarado; Sinéad B Chapman; Nomonde R Mvelase; Eamon Y Duffy; Michael G Fitzgerald; Pamla Govender; Sharvari Gujja; Susanna Hamilton; Clinton Howarth; Jeffrey D Larimer; Kashmeel Maharaj; Matthew D Pearson; Margaret E Priest; Qiandong Zeng; Nesri Padayatchi; Jacques Grosset; Sarah K Young; Jennifer Wortman; Koleka P Mlisana; Max R O'Donnell; Bruce W Birren; William R Bishai; Alexander S Pym; Ashlee M Earl
Journal:  PLoS Med       Date:  2015-09-29       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.